JCO Precis Oncol
Dr. Mahdi Taha, DO
- Medicare services, 2024
- 110,906
- Medicare patients, 2024
- 377
- Part D claims, 2024
- 1,396
- Publications
- 1
- MIPS score, 2024
- 75
- Practice address
- 1200 East 3900 South, Salt Lake City, UT 84124
- Practice phone
- Call (801) 268-7111
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Taha's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Mahdi Taha is a medical oncologist in Salt Lake City, Utah
Dr. Taha practices at St. Mark's Hospital in Salt Lake City, Utah, part of HCA Healthcare.
Dr. Taha's NPI, 1346488061, was assigned on February 3, 2009. Dr. Taha graduated from New York Institute of Technology College of Osteopathic Medicine - Old Westbury in 2006. Dr. Taha holds Florida license OS17126.
- NPI
- 1346488061NPI Registry (opens in a new tab)
- Medicare PAC ID
- 8527216035
- NPI enumeration date
- February 3, 2009
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Practice phone
- (801) 268-7111
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 50
- Medical school graduation
- 2006
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Mahdi Taha practices at St. Mark's Hospital in Salt Lake City, Utah
Dr. Taha's primary practice is St. Mark's Hospital, at 1200 East 3900 South, Salt Lake City, UT 84124 in Salt Lake County. The practice phone is (801) 268-7111.
- St. Mark's Hospital1200 East 3900 South, Salt Lake City, UT 84124 · Salt Lake CountyPhone(801) 268-7111
Source: Dmand AI Affiliation Data
Dr. Mahdi Taha is affiliated with 5 sites of care and 3 medical groups
Dr. Taha's primary practice is St. Mark's Hospital in Salt Lake City, Utah, part of HCA Healthcare. Dr. Taha is also affiliated with Sylvester Comprehensive Cancer Center. The medical group on file is University of Miami Health System. Dmand AI also links Dr. Taha to 1 more hospital, 2 group practices and clinics and 2 medical groups, each named with a free account.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Mahdi Taha's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Taha practices, 5 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| St. Mark's Hospital | Available with a free account |
| +4 more sites and 2 medical groups | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across HCA Healthcare and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Mahdi Taha is one of 39 medical oncologists in Utah
Medical oncology is Dr. Taha's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Taha is board certified in internal medicine by the AOA Board of Internal Medicine. Dr. Taha is licensed in Florida.
Specialties and state licenses
- Medical oncology, FloridaPrimary
Clinical focus
Dmand AI lists breast cancer, chronic anemia, colorectal cancer, fluid and electrolyte imbalances, lung cancer, lymphoma, multiple myeloma and neutropenia among the conditions Dr. Taha treats.
Medical oncologists near Dr. Taha
Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Mahdi Taha billed Medicare for 110,906 services in 2024
CMS data shows 110,906 Medicare services from Dr. Taha across 37 procedure codes in 2024, for 377 Medicare patients. Medicare paid $2,792,529 for them.
Dr. Taha's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Drugs given in the office
- 2023: 87,4452024: 98,55613%
- Tests and treatments
- 2023: 2,7822024: 3,58229%
- Office and hospital visits
- 2023: 1,8162024: 2,58442%
- Lab and pathology
- 2023: 2,0562024: 2,52823%
- Surgery
- 2023: 1,8662024: 2,38528%
- Other services
- 2023: 02024: 1,271
Where Dr. Taha's Medicare services took place, 2024
- In an office110,754100%
- In a facility1520%
Dr. Taha compared with the Utah median for medical oncologists, 2024
- Dr. Taha
- Utah median
- Medicare services
- 110,906vs 644172.2 times
- Medicare patients
- 377vs 1382.7 times
- Part D claims
- 1,084vs 3293.3 times
Medians across 39 medical oncologists in Utah with Dmand AI profiles that report each measure.
Dr. Taha's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Taha?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Taha and other medical oncologists in Utah.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Mahdi Taha treated 377 Medicare patients in 2024, average age 77
CMS counts 377 Medicare patients who saw Dr. Taha in 2024. The largest group is 75 to 84, with 164 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 2.30, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Taha's median patient age at 70, with 47% women.
Dr. Taha's Medicare patients by age, 2024
CMS leaves out age groups with fewer than 11 patients.
Dr. Taha's Medicare patients by sex, 2024
- Women16945%
- Men20855%
Chronic conditions among Dr. Taha's Medicare patients, 2024
- High blood pressure75%
- High cholesterol75%
- Cancer62%
- Arthritis51%
- Ischemic heart disease45%
- Chronic kidney disease36%
- Osteoporosis31%
- Mood disorders29%
Share of Medicare patients with each condition. A patient can have several.
Dr. Taha's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 70
Patient panel by sex, all payers
- Women47%
- Men52%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Mahdi Taha wrote 1,396 Medicare Part D claims in 2024
In 2024, Dr. Taha wrote 1,396 Medicare Part D claims for 224 patients. 64% of them were for generic drugs. CMS names the drug for 1,084 of them, across 37 drugs with 11 or more claims each, at $3,614,274 in total drug cost. In 2023, CMS named 825 claims across 29 drugs.
Dr. Taha's Part D claims by kind of drug, 2024
- Generic887 claims64%
- Brand-name497 claims36%
- Other12 claims1%
Dr. Taha's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Taha's Part D claims, 2024
- Opioids2%31 of 1,396 claims
- Antibiotics5%75 of 1,396 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 8252024: 1,08431%
Drugs named by CMS: 37 in 2024, 29 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Mahdi Taha scored 75 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Taha for performance year 2024, reported as part of a group. Dr. Taha accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Taha as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- MIPS final score, 2024
- 75 of 100
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Mahdi Taha has 1 publication on record
Dmand AI links 1 paper to Dr. Taha.
Recent publications by Dr. Taha
See who Dr. Taha researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Taha works with, so you can find a warm path to the right medical oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Mahdi Taha received $1,881,167 in industry payments from 2016 to 2025
CMS Open Payments shows 3,486 general payments to Dr. Taha from 85 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 63% of the total. Janssen Pharmaceuticals, Inc paid the most, $549,581.
General payments to Dr. Taha by program year, 2016 to 2025
General payments to Dr. Taha by kind, 2016 to 2025
- Speaker and faculty fees$1,192,38463%
- Travel and lodging$257,48414%
- Consulting fees$190,80710%
- Compensation for serving as faculty or as a speaker for a medical education program$153,5998%
- Other$85,2565%
Companies that paid Dr. Taha the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Mahdi Taha graduated from New York Institute of Technology College of Osteopathic Medicine - Old Westbury
Dr. Taha graduated from New York Institute of Technology College of Osteopathic Medicine - Old Westbury in 2006. Dr. Taha is a member of AOA.
- Medical school
- Board certified in internal medicine
- Board certified in oncology
- Board certified in 2020 - 2026
- Board certified in 2014 - 2026
- Board certified in 2007 - 2013
- Board certified in 2011 - 2011
- Board certified in 2008 - 2026
- Board certified in 2011 - 2015
- Board certified in 2011 - 2012
Source: Dmand AI Professional Profile Data
Dr. Mahdi Taha accepts plans from 18 insurance carriers
Dr. Taha is in network with 18 carriers, including Elevance, Aetna and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.
- Elevance
- Aetna
- United Healthcare
- Cigna
- HCSC
- Humana
- Aspirus Health Plan
- Blue Cross Blue Shield of Massachusetts
- +10 more carriersWith a free account
Plan types Dr. Taha accepts, by number of carriers
- PPO11
- HMO10
- Medicare9
- EPO4
- POS4
- Medicaid2
Source: Dmand AI Insurance Network Data
Sources for Dr. Mahdi Taha's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Mahdi Taha
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Mahdi Taha's NPI number?
Dr. Mahdi Taha's NPI number is 1346488061. It was assigned on February 3, 2009, and it is active in the NPI Registry.
What kind of doctor is Dr. Mahdi Taha?
Dr. Mahdi Taha is a medical oncologist in Salt Lake City, Utah. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).
Where does Dr. Mahdi Taha practice?
Dr. Taha practices at 1200 East 3900 South, Salt Lake City, UT 84124. Dr. Taha's primary practice is St. Mark's Hospital in Salt Lake City, Utah, part of HCA Healthcare. Dmand AI also links Dr. Taha to 1 hospital, 2 group practices and clinics and 2 medical groups.
What is Dr. Mahdi Taha's office phone number?
The practice phone on file for Dr. Taha is (801) 268-7111.
What is Dr. Mahdi Taha's medical license number?
Dr. Taha holds Florida license OS17126.
Which hospitals is Dr. Mahdi Taha affiliated with?
Dr. Taha practices at St. Mark's Hospital in Salt Lake City, Utah. Dr. Taha is also affiliated with Sylvester Comprehensive Cancer Center. Dmand AI links Dr. Taha to 1 more hospital.
What medical group is Dr. Mahdi Taha part of?
Dr. Taha is linked to University of Miami Health System. Dmand AI links Dr. Taha to 2 more medical groups.
Does Dr. Mahdi Taha accept Medicare?
Yes. CMS data shows Dr. Taha billed Medicare for 110,906 services in 2024, and Dr. Taha accepts Medicare assignment.
Does Dr. Mahdi Taha offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Taha as offering telehealth services.
What is Dr. Mahdi Taha's MIPS score?
Dr. Taha's MIPS final score for performance year 2024 is 75 out of 100, reported as part of a group.
Show 9 more questionsShow fewer questions
How many Medicare patients does Dr. Mahdi Taha see?
CMS counts 377 Medicare patients who saw Dr. Taha in 2024, with an average age of 77.
Is Dr. Mahdi Taha board certified?
Yes. Dr. Taha is board certified in internal medicine by the AOA Board of Internal Medicine.
What services does Dr. Mahdi Taha bill to Medicare?
In 2024, Dr. Taha's most billed Medicare services were injected or infused drug (J0897), injected or infused drug (J9271) and injected or infused drug (J1756).
Where did Dr. Mahdi Taha go to medical school?
Dr. Taha graduated from New York Institute of Technology College of Osteopathic Medicine - Old Westbury in 2006.
What drugs does Dr. Mahdi Taha prescribe most?
In 2024 Medicare Part D data, Dr. Taha's most prescribed drugs by claims were Erleada, Prednisone and Ondansetron ODT.
Has Dr. Mahdi Taha received payments from drug or device companies?
CMS Open Payments shows $1,881,167 in general payments to Dr. Taha from 85 companies from 2016 to 2025. The largest total came from Janssen Pharmaceuticals, Inc.
How long has Dr. Mahdi Taha been practicing?
Dr. Taha graduated from medical school in 2006, 20 years ago.
Does Dr. Mahdi Taha do research?
Dmand AI links 1 publication to Dr. Taha.
What insurance does Dr. Mahdi Taha accept?
Dr. Taha is in network with 18 carriers, including Elevance, Aetna and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.
Selling to medical oncology practices?
See medical oncologists in Utah by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card